Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-173,300
Closed -$16.1M 6746
2025
Q4
$16.1M Buy
173,300
+105,800
+157% +$11.5M ﹤0.01% 2588
2025
Q3
$8.41M Buy
+67,500
New +$8.58M ﹤0.01% 3138
2017
Q1
Sell
-1,500
Closed -$94K 6884
2016
Q4
$94K Hold
1,500
﹤0.01% 6169
2016
Q3
$84K Buy
+1,500
New +$71.9K ﹤0.01% 6309
2016
Q1
Sell
-100
Closed -$4K 7194
2015
Q4
$4K Sell
100
-1,100
-92% -$38.8K ﹤0.01% 7059
2015
Q3
$38K Buy
1,200
+1,100
+1,100% +$34.3K ﹤0.01% 6877
2015
Q2
$3K Sell
100
-2,100
-95% -$76.3K ﹤0.01% 7215
2015
Q1
$80K Sell
2,200
-7,200
-77% -$268K ﹤0.01% 6521
2014
Q4
$398K Buy
9,400
+5,100
+119% +$204K ﹤0.01% 5495
2014
Q3
$169K Buy
4,300
+4,000
+1,333% +$160K ﹤0.01% 6291
2014
Q2
$12K Sell
300
-600
-67% -$22.8K ﹤0.01% 6918
2014
Q1
$32K Buy
900
+800
+800% +$30.3K ﹤0.01% 6640
2013
Q4
$4K Buy
+100
New +$4.24K ﹤0.01% 6608

Other funds holding ITRI

Goldman Sachs's ITRI Position: Q1 2026 in Review

Goldman Sachs reduced its Itron (ITRI) stake by 14% in Q1 2026, selling an estimated $7.68M and leaving 486,755 shares worth $43.6M. The position accounts for 0.01% of the portfolio, ranked #1689.

Goldman Sachs first reported a position in ITRI in Q2 2013 and has held it in 52 quarters since. The position peaked at $129M in Q2 2025. 431 funds tracked by Wall St. Rank hold ITRI as of Q1 2026.

  • Goldman Sachs held 486,755 shares of Itron worth $43.6M as of Q1 2026.
  • Goldman Sachs sold 79,948 Itron shares in Q1 2026, an estimated $7.68M.
  • Itron made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1689 holding.
  • Goldman Sachs first reported a position in Itron in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Itron position peaked at $129M in Q2 2025.
  • 431 funds tracked by Wall St. Rank held Itron as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.